1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2015 Update

Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2015 Update

  • September 2015
  • -
  • GlobalData
  • -
  • 33 pages

Summary

Table of Contents

Search Inside

Summary

Vermillion, Inc. (Vermillion) is a healthcare service provider that develops and commercializes multi-marker, diagnostic tests which addresses unmet needs in gynecologic oncology and women’s health. The company’s products includes OVA1 product. Its OVA1 is a simple blood test which measures the levels of five proteins found in the blood and then uses a proprietary software called OvaCalc to calculate a single score. Vermillion’s research and development center develops and validates biomarkers and algorithms. The company collaborates with other academic institutions in oncology, cardiology and women’s health. Vermillion is headquartered in Austin, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vermillion, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Ovarian Cancer - Pipeline Review, H2 2016

Ovarian Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview ...

High-Grade Glioma - Pipeline Review, H2 2016

High-Grade Glioma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

High-Grade Glioma - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma – Pipeline Review, H2 2016, provides an overview ...

Cancer Research UK - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cancer Research UK - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2017
  • by GlobalData

Summary Cancer Research UK (CRUK) is a research institution that offers clinical research services. The institute offers cancer research services for anal cancer, bile duct cancer, bladder cancer, bone ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.